1. Home
  2. MSLE vs SGMT Comparison

MSLE vs SGMT Comparison

Compare MSLE & SGMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MSLE

Satellos Bioscience Inc. Common Stock

N/A

Current Price

$7.30

Market Cap

173.9M

Sector

N/A

ML Signal

N/A

Logo Sagimet Biosciences Inc. Series A

SGMT

Sagimet Biosciences Inc. Series A

HOLD

Current Price

$4.59

Market Cap

169.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSLE
SGMT
Founded
N/A
2006
Country
Canada
United States
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
173.9M
169.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
MSLE
SGMT
Price
$7.30
$4.59
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$26.38
AVG Volume (30 Days)
104.5K
296.4K
Earning Date
N/A
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,000,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.67
$1.73
52 Week High
$13.39
$11.41

Technical Indicators

Market Signals
Indicator
MSLE
SGMT
Relative Strength Index (RSI) 32.85 33.31
Support Level $6.67 N/A
Resistance Level $8.37 $6.62
Average True Range (ATR) 0.84 0.25
MACD -0.25 -0.07
Stochastic Oscillator 12.01 0.74

Price Performance

Historical Comparison
MSLE
SGMT

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.

Share on Social Networks: